Multiple sclerosis campaigners will step up their bid to persuade Scotland’s medicines regulator to overturn its decision to reject a new treatment for the disease.
The Multiple Sclerosis Society Scotland yesterday said it would be writing to the Scottish Medicines Consortium (SMC) to try to convince the regulator it should approve the use of fingolimod.
Pressure mounted on the SMC after its equivalent body south of the Border, the National Institute for Health and Clinical Excellence (NICE), approved the drug in England and Wales.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
